|
Market Closed -
Hong Kong S.E.
07:08:20 21/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.7200 HKD | -4.00% |
|
+5.11% | -84.14% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 238.2 | - | - |
| Change | - | -30.05% | -30.06% | -83.93% | - | - |
| Enterprise Value (EV) | 2,471 | 2,055 | 1,469 | 238.2 | 238.2 | 238.2 |
| Change | - | -16.83% | -28.53% | -83.78% | 0% | 0% |
| P/E | -1.04x | -4.72x | -3.96x | 21.3x | 4.56x | - |
| PBR | 2.25x | 2.17x | 1.52x | 0.36x | 0.34x | - |
| PEG | -0x | 0.1x | 0.1x | -0x | 0x | - |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 0.41x | 0.25x | 0.18x |
| EV / Revenue | 0x | 0x | 0x | 0.41x | 0.25x | 0.18x |
| EV / EBITDA | -0x | -0x | -0x | 9.16x | 3.31x | - |
| EV / EBIT | -0x | -0x | -0x | 23.8x | 4.33x | 2.46x |
| EV / FCF | -0x | -0x | -0x | -8.21x | -7.44x | -5.67x |
| FCF Yield | -14.4% | -22.1% | -20.4% | -12.2% | -13.4% | -17.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | 0.03 | 0.14 | - |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 588 | 961 | 1,336 |
| EBITDA 1 | -498 | -419.9 | -257.9 | 26 | 72 | - |
| EBIT 1 | -538.9 | -461.1 | -300.1 | 10 | 55 | 97 |
| Net income 1 | -1,964 | -433.8 | -340.2 | 10 | 50 | - |
| Net Debt | -559.6 | -64.73 | -13.8 | - | - | - |
| Reference price 2 | 9.9667 | 6.6531 | 4.0798 | 0.6383 | 0.6383 | 0.6383 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 373,171 | - | - |
| Announcement Date | 27/3/24 | 24/3/25 | 24/3/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.28x | - | - | - | 35.66M | |
| 36.99x | 13.22x | 28x | 0.53% | 1,144B | |
| 37.96x | 6.39x | 17.99x | 2.06% | 625B | |
| 36.9x | 8.47x | 17.49x | 2.38% | 511B | |
| 21.13x | 5.1x | 12.68x | 2.57% | 377B | |
| 108.1x | 6.04x | 25.89x | 2.3% | 366B | |
| 21.5x | 5.61x | 13.79x | 2.85% | 291B | |
| 22.06x | 4.46x | 12.76x | 1.98% | 262B | |
| 27.87x | 7.15x | 12.8x | 2.3% | 237B | |
| -45.73x | 7.01x | 27.13x | 2.11% | 194B | |
| Average | 28.81x | 7.05x | 18.73x | 2.12% | 400.79B | |
| Weighted average by Cap. | 35.48x | 8.34x | 20.49x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
